JPRN-UMIN000000903已完成1 期
Phase I study of TS-1+CDDP+PTX therapy in patients with advanced/recurrent gastric cancer (OGSG 0703) - OGSG 0703
OGSG0 个研究点目标入组 6 人开始时间: 2007年11月24日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) with fresh intestinal bleeding 2) patient who cannot be administered anticancer agents due to intestinal obstraction 3) history of severe allergy against drug 4) with severe thoracic fluid and/or ascites 5) with severe diseases (infection, interstitial pneumonitis, pulmonary fibrosis, cardiac failure, liver dysfunction, renal dysfunction or uncontrolled DM) which disturb registration to this study 6) with liver scirrhosis and/ or jaundice 7) patients with mental disprder who need medicines and/or treatments 8) with brain metastasis and its symptoms 9) with active double cancer 10) pregnant women or women who like to be pregnant 11) doctor's dicision not to be registered to this study
研究者
相似试验
已完成
2 期
Phase II study of preoperative TS-1+CDDP therapy for advanced gastric cancer (OGSG 0004)Patients with unresectable gastric cancer due to limited inavasion or metastasis.JPRN-UMIN000000934OGSG30
已完成
不适用
A pharmaco-kinetic study on TS-1+CDDP+PTXtreatment for advanced and/or metastatic gastric cancer (OGSG 0703 plus)advanced and/or metastatic gastric cancerJPRN-UMIN000002951OGSG6
已完成
1 期
A Phase I/II study of combination of TS-1, CDDP plus PTX in patients with advanced/recurrent gastric cancer (OGSG 0703)JPRN-UMIN000002183OGSG40
招募中
不适用
PhaseI/II study of TS-1+CDDP in combination with Radiotherapy with unresectable and locally advanced for biliary tract cancerBiliary tract cancerJPRN-UMIN000007473Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University25
已完成
1 期
PhaseI/II study of neoadjuvant TS-1+CDDP with concurrent radiation for biliary tract cancerBiliary tract cancerJPRN-UMIN000009028Keio University School of Medicine40